HOME
Leading the way to a cure

LUPUS NEWS

Tacrolimus Therapy Effective, Safe for Patients with Lupus Nephritis

December 28, 2012

Low-dose tacrolimus therapy for patients with refractory lupus nephritis who were resistant to cyclophosphamide was effective and safe, according to study results.

Researchers in China evaluated 26 patients with lupus nephritis (LN; mean age, 29.36 years; 22 women) with persistent proteinuria who were resistant to cyclophosphamide (CYC) treatment (>8 g in less than 6 months). Patients had a mean duration of systemic lupus erythematosus (SLE) of 5.20 years and a mean duration of LN of 2.91 years.

***

Click here to read the full article.

Source: Healio Rheumatology


Tacrolimus Therapy Effective, Safe for Patients with Lupus Nephritis

December 28, 2012

Low-dose tacrolimus therapy for patients with refractory lupus nephritis who were resistant to cyclophosphamide was effective and safe, according to study results.

Researchers in China evaluated 26 patients with lupus nephritis (LN; mean age, 29.36 years; 22 women) with persistent proteinuria who were resistant to cyclophosphamide (CYC) treatment (>8 g in less than 6 months). Patients had a mean duration of systemic lupus erythematosus (SLE) of 5.20 years and a mean duration of LN of 2.91 years.

***

Click here to read the full article.

Source: Healio Rheumatology



1.5 million

people in the U.S. have Lupus.

100 million

dollars committed to lupus research by the Alliance for Lupus Research.


We're walking across the United States to raise awareness and funds for lupus research.

Can't make it? Join our National Virtual Walk to participate anytime, anywhere.


Show your support by visiting the Alliance for Lupus Research online store. Discover the perfect gift, or prepare for a walk with our selection of apparel and accessories.

Powered by Convio
nonprofit software